Prescription Required.
Is the active ingredient. formulations may also include inactive ingredients such as fillers, binders, and coatings that vary depending on the brand and dosage form (e.g., capsules, tablets).
Treatment of hypertriglyceridemia (high levels of triglycerides in the blood)
Treatment of mixed dyslipidemia (high levels of both cholesterol and triglycerides) in patients who have not responded adequately to diet and other nonpharmacological treatments.
May be used as part of a broader strategy to reduce cardiovascular risk in patients with high triglycerides.
Fenobate 67mg Cap (Fenofibrate) is a fibrate drug that lowers triglyceride levels by activating peroxisome proliferator-activated receptor alpha (PPAR-α). This activation increases the breakdown of triglycerides and reduces the production of very-low-density lipoproteins (VLDLs), thereby lowering triglyceride levels and improving HDL cholesterol levels.
Store at room temperature, away from moisture and direct sunlight. Keep out of reach of children. Check the specific storage instructions on your prescription label.
Dosage varies depending on individual patient needs and response to treatment. Your doctor will determine the appropriate dose for you.
Follow your doctor's instructions carefully. Do not stop taking the medication without consulting your doctor.
Typically taken once daily, usually with food, to minimize gastrointestinal side effects.
Gastrointestinal disturbances (e.g., nausea, diarrhea, abdominal pain)
Elevated liver enzymes (liver function abnormalities)
Gallstones
Headache
Fatigue
Skin rash
Alcohol consumption may increase the risk of liver damage. Limit alcohol intake while taking fenofibrate.
Fenofibrate may cause drowsiness or dizziness in some individuals. Avoid driving or operating machinery if affected.
Consult your doctor before using fenofibrate if you are pregnant, breastfeeding, or plan to become pregnant. The safety of fenofibrate during pregnancy and breastfeeding has not been fully established.
The use of fenofibrate in children is generally not recommended unless specifically prescribed by a doctor.
Kidney problems can impact the metabolism and excretion of fenofibrate, potentially leading to increased side effects. Dosage adjustments may be necessary for patients with kidney disease.
Liver function should be monitored regularly during treatment with fenofibrate, as it can potentially cause liver damage. Fenofibrate should be used cautiously in patients with pre-existing liver disease.
Consult your doctor or pharmacist for more detailed information and references.
Package insert of your specific fenofibrate medication.
